A strategy to reduce the carbon footprint of clinical trials-Reference-Cited by-同舟云学术

A strategy to reduce the carbon footprint of clinical trials

Published:2021-07 Issue:10297 Volume:398 Page:281-282
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Adshead Fiona,Al-Shahi Salman Rustam,Aumonier Simon,Collins Michael,Hood Kerry,McNamara Carolyn,Moore Keith,Smith Richard,Sydes Matthew R,Williamson Paula R

Funder

Novartis

Janssen Pharmaceuticals

Pfizer

Astellas Pharma US

Publisher

Elsevier BV

Subject

General Medicine

Reference9 articles.

1. Towards sustainable clinical trials;BMJ,2007

2. Reducing the environmental impact of trials: a comparison of the carbon footprint of the CRASH-1 and CRASH2 clinical trials;Subaiya;Trials,2011

3. Carbon cost of pragmatic randomised controlled trials: retrospective analysis of sample of trials;Lyle;BMJ,2009

4. The 2020 report of the Lancet Countdown on health and climate change: responding to converging crises;Watts;Lancet,2021

5. Delivering a “net zero” National Health Service,2020

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Consideration of Sustainability When Approving Human Medical Research—A Scoping Review;Journal of Bioethical Inquiry;2024-07-25

2. An urgent call for environmental accountability in nephrology clinical trials;Clinical Kidney Journal;2024-06-17

3. Registry-based randomised controlled trials: conduct, advantages and challenges—a systematic review;Trials;2024-06-11

4. Defending and Defining Environmental Responsibilities for the Health Research Sector;Science and Engineering Ethics;2024-06-06

5. Getting our ducks in a row: The need for data utility comparisons of healthcare systems data for clinical trials;Contemporary Clinical Trials;2024-06